This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein: A Review | Cardiology | JAMA | JAMA Network https://t.co/9bnVSkSSMV
Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2024 – Apr 2025Where it's discussed
-
X / Twitter88 posts
-
Facebook3 posts
-
YouTube2 videos
-
Blogs2 articles
AI synopsis
What people are saying
Several posts highlight the significance of the publication, with comments such as 'This is really good,' and praise for the authors, indicating the reviewers' appreciation of the work. The use of terms like 'comprehensive review' and 'must read' emphasizes a positive and engaging tone, contributing to the overall sentiment of agreement and interest in the discussion.
There is a consensus among posters expressing strong support for the publication's findings and its authors.
Discussion participants show high curiosity and relevance regarding the topic of cardiac amyloidosis.
While some posts are brief, a few delve deeper into the content, suggesting a varying level of engagement.
Many users believe that the article has significant implications for understanding and treating cardiac amyloidosis.
Abstract in brief
- Systemic amyloidosis from transthyretin (ATTR) is the most common form causing heart issues, specifically cardiomyopathy, due to misfolded TTR protein accumulating in the heart.
- While wildtype ATTR typically leads to heart-related problems, genetic variants can result in both heart and nerve disorders, affecting about 50,000 to 150,000 individuals in the US.
- Diagnosis involves specific lab tests to differentiate it from other types of amyloidosis, and treatments mainly include loop diuretics to manage symptoms, with research ongoing into therapies targeting protein misfolding.
Top posts
Most liked on X and BlueskyJAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT4wN64dv
Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that slows production of ATTR amyloidosis and improves survival and prevents hospitalization. Read the Review. https://t.co/9fT2XIR5hP https://t.co/UmfDjhlNPN
Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
Cardiac Amyloidosis Due to Transthyretin Protein. Review in @JAMA_current https://t.co/xh5PQJaqhN @secardiologia @SVCardio #amyloid #CardioEd https://t.co/WDMyUULS0Y
All mentions
Understanding Heart Failure from Transthyretin Amyloidosis
Systemic amyloidosis from transthyretin (ATTR) is a common cause of heart failure, particularly in older adults. This video discusses the diagnosis and treatment of ATTR cardiomyopathy, including lab tests, symptom…
Impact of V142I Transthyretin Variant on Cardiac Health in Blacks
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @Ed_Alania: https://t.co/x1Mp4r3t7m
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @BU_Amyloidosis: Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of @BU_Amyloidosis. https://t.co/ZTCFjgETlF
RT @ValleAlfonso:
Cardiac Amyloidosis Due to Transthyretin Protein https://t.co/QPmhjYcJql
Cardiac Amyloidosis Due to Transthyretin Protein https://t.co/4LabhuoTgu
Cardiac Amyloidosis Due to Transthyretin Protein - A Review
RT @ValleAlfonso:
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @ValleAlfonso:
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @ValleAlfonso:
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @ValleAlfonso:
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @ValleAlfonso:
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
RT @MHcsba: JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT…
JAMA 2024: Amiloidosis cardiaca secundaria a transtiretina doi:10.1001/jama.2024.0442 #MedEd #MedTwitter #MedX https://t.co/1cT4wN64dv
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @FormigaFrancesc: Cardiac Amyloidosis Due to Transthyretin Protein https://t.co/94q4aa5rLn @IcyfaSemi
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @ValleAlfonso:
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @ValleAlfonso:
https://t.co/dMhdKermqX
https://t.co/V8RLplobuL
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @ValleAlfonso:
RT @ValleAlfonso:
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @ValleAlfonso:
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @ValleAlfonso:
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @FormigaFrancesc: Cardiac Amyloidosis Due to Transthyretin Protein https://t.co/94q4aa5rLn @IcyfaSemi
RT @ValleAlfonso:
RT @ValleAlfonso:
RT @ValleAlfonso:
RT @Ed_Alania: https://t.co/x1Mp4r3t7m
Cardiac Amyloidosis Due to Transthyretin Protein https://t.co/94q4aa5rLn @IcyfaSemi
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
RT @BrettSperryMD: This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein…
Cardiac Amyloidosis Due to Transthyretin Protein: A Review | Cardiology | JAMA | JAMA Network https://t.co/IynnpOl8AP
This is really good. Congrats @frederickruberg and @MathewMaurer! Cardiac Amyloidosis Due to Transthyretin Protein: A Review | Cardiology | JAMA | JAMA Network https://t.co/9bnVSkSSMV
RT @gglinskii: Cardiac Amyloidosis Due to Transthyretin Protein A Review https://t.co/R5Sr8DfffM
Cardiac Amyloidosis Due to Transthyretin Protein A Review https://t.co/R5Sr8DfffM
RT @JAMA_current: Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that s…
RT @JAMA_current: Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that s…
RT @Ed_Alania: https://t.co/x1Mp4r3t7m
https://t.co/x1Mp4r3t7m
RT @JAMA_current: Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that s…
Cardiac Amyloidosis Due to Transthyretin Protein. Review in @JAMA_current https://t.co/xh5PQJaqhN @secardiologia @SVCardio #amyloid #CardioEd https://t.co/WDMyUULS0Y
RT @JAMA_current: Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that s…
RT @JAMA_current: Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that s…
Amyloidosis from transthyretin (ATTR) can cause cardiomyopathy. Tafamidis is the only currently approved therapy that slows production of ATTR amyloidosis and improves survival and prevents hospitalization. Read the Review. https://t.co/9fT2XIR5hP https://t.co/UmfDjhlNPN
Cardiac Amyloidosis Due to Transthyretin Protein: A Review https://t.co/QaTUyhWY15 https://t.co/XVy0KpyukB